Cardiovascular Disease

Showing NaN - NaN of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Disease, Alcohol Use Disorder, HIV Risk Trial in New York (Navigation, compensation, and personalization)

Not yet recruiting
  • Cardiovascular Disease
  • +3 more
  • Navigation, compensation, and personalization
  • New York, New York
    NYC H+H/Bellevue
Apr 13, 2023

Cardiovascular Disease, Myocardial Infarction, Stroke Trial (Evolocumab, Routine Lipid Management)

Recruiting
  • Cardiovascular Disease
  • +3 more
  • Fairhope, Alabama
  • +14 more
Dec 21, 2022

Patients With Heart Failure Using HeartLogic

Completed
  • Heart Failure
  • +5 more
  • HeartLogic Sensors
  • Birmingham, Alabama
  • +87 more
Oct 24, 2022

Sleep, Cardiovascular Disease, Obesity Trial in New York (Sleep Restriction)

Completed
  • Sleep
  • +2 more
  • Sleep Restriction
  • New York, New York
    New York Obesity Nutrition Research Center
May 11, 2022

Cardiovascular Disease, Acute Coronary Syndrome Trial in United States (Multifaceted Intervention with pharmacist and IVR)

Completed
  • Cardiovascular Disease
  • Acute Coronary Syndrome
  • Multifaceted Intervention with pharmacist and IVR
  • Aurora, Colorado
  • +14 more
Feb 8, 2022

Clinical Outcomes: An InteRnational Multicenter Registry

Completed
  • Atherosclerosis
  • +2 more
    • Los Angeles, California
    • +19 more
    Jan 12, 2022

    Cardiovascular Disease Trial in New York (control group, Lifestyle management)

    Completed
    • Cardiovascular Disease
    • control group
    • Lifestyle management
    • New York, New York
      NYU Langone
    Dec 7, 2021

    Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)

    Completed
    • Heart Failure
    • +4 more
    • Darbepoetin alfa
    • Placebo
    • Birmingham, Alabama
    • +753 more
    Oct 31, 2021

    Circulating Donor-Specific DNA in Organ Transplant Recipients

    Completed
    • Cardiovascular Disease
    • +3 more
    • Blood Draw of up to 10 ml
    • Little Rock, Arkansas
    • +7 more
    Mar 23, 2021

    Cardiovascular Disease, Interventional Cardiology Trial in New York (Aspirin, Placebo, ticagrelor)

    Completed
    • Cardiovascular Disease
    • Interventional Cardiology
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 23, 2020

    Cardiovascular Disease Trial in United States (DEFINITY®)

    Completed
    • Cardiovascular Disease
    • San Diego, California
    • +15 more
    Nov 6, 2020

    Elevated Lipoprotein(a), Cardiovascular Disease Trial in Worldwide (ISIS 681257, Placebo)

    Completed
    • Elevated Lipoprotein(a)
    • Cardiovascular Disease
    • ISIS 681257
    • Placebo
    • Cottonwood, Arizona
    • +31 more
    Oct 26, 2020

    Osteoarthritis, Cardiovascular Disease Trial in New York (Metoprolol, Lisinopril, Atorvastatin)

    Terminated
    • Osteoarthritis
    • Cardiovascular Disease
    • New York, New York
      NYU Hospital for Joint Diseases
    Jul 20, 2020

    Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)

    Completed
    • Cardiovascular Disease
    • Birmingham, Alabama
    • +469 more
    Jul 23, 2020

    Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)

    Terminated
    • Cardiovascular Disease
    • Los Angeles, California
    • +109 more
    Mar 20, 2020

    Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease Trial in United States

    Completed
    • Hyperlipidemia
    • +16 more
      • Little Rock, Arkansas
      • +13 more
      Feb 27, 2020

      Elevated Triglycerides, Diabetes, Cardiovascular Disease Trial in New York (Fructose + Glucose Beverage)

      Completed
      • Elevated Triglycerides
      • +3 more
      • Fructose + Glucose Beverage
      • New York, New York
      • +1 more
      Jun 14, 2019

      Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

      Completed
      • Cardiovascular Disease
      • +4 more
      • Lorcaserin hydrochloride
      • Placebo
      • Alexander City, Alabama
      • +498 more
      Jun 27, 2019

      Cardiovascular Disease, High Blood Pressure Trial in New York (Million Hearts ABCS 6 Months, Million Hearts ABCS 9 Months,

      Completed
      • Cardiovascular Disease
      • High Blood Pressure
      • Million Hearts ABCS 6 Months
      • +15 more
      • New York, New York
        New York University School of Medicine
      May 17, 2019

      Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

      Terminated
      • Cardiovascular Disease
      • bococizumab (PF-04950615)
      • Placebo
      • Athens, Alabama
      • +1595 more
      Apr 18, 2019

      Platelet Activity in Vascular Surgery and Cardiovascular Events

      Completed
      • Cardiovascular Disease
      • +2 more
        • New York, New York
          NYU Langone Medical Center and School of Medicine
        Dec 4, 2018

        Palliative Medicine, Cardiovascular Disease Trial in United States (discontinue statins)

        Completed
        • Palliative Medicine
        • Cardiovascular Disease
        • discontinue statins
        • Birmingham, Alabama
        • +14 more
        Aug 22, 2018

        Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

        Terminated
        • Cardiovascular Disease
        • bococizumab (PF-04950615)
        • Placebo
        • Athens, Alabama
        • +1745 more
        Jun 14, 2018

        Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)

        Completed
        • Cardiovascular Disease
        • Decatur, Georgia
        • +202 more
        Jun 12, 2018

        Cardiovascular Disease Trial in United States (EVARREST™, Topical hemostat, Standard of Care)

        Completed
        • Cardiovascular Disease
        • EVARREST™
        • +2 more
        • Indianapolis, Indiana
        • +5 more
        May 18, 2018